Eirion Therapeutics
PrivateLast Round
Series A
Mar 9, 2021
Total Funding Raised
$43M
Company Overview
Eirion Therapeutics is a biopharmaceutical company that develops prescription products for aesthetic dermatology, including treatments for wrinkles, hyperhidrosis, hair loss, and hair greying.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Fashion & Beauty
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eirion Therapeutics Comparables
Compare Eirion Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AbbVie | 74% | |
| Amplifica Holdings Group, Inc. | 73% | |
| Merz | 72% | |
Eirion Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 9, 2021 |
Key People
Founding team and executive leadership
Eirion Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gore Range Capital | Series A |
| Kinled Holding | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2025
Will present at the Society for Investigative Dermatology 2025 annual meeting.
Eirion Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Eirion Therapeutics's valuation, stock price, and market status.